Endobronchial tuberculosis

Area of Science:

• Pulmonology
• Infectious Diseases
• Medical Research

Background:

• Endobronchial tuberculosis (EBTB) is a difficult-to-diagnose infectious respiratory condition.
• Delayed diagnosis of EBTB often leads to severe bronchial stenosis, atelectasis, and bronchiectasis.
• The pathogenesis and varied clinical courses of EBTB present significant therapeutic challenges.

Purpose of the Study:

• To review the diagnostic and therapeutic challenges of Endobronchial Tuberculosis (EBTB).
• To analyze the prognosis and outcomes associated with different types of EBTB.
• To evaluate current and potential future treatment strategies for EBTB and its sequelae.

Main Methods:

• Review of existing literature on Endobronchial Tuberculosis.
• Analysis of EBTB classification, pathogenesis, and clinical course.
• Evaluation of treatment efficacy, including chemotherapy, steroid therapy, balloon dilatation, and stent insertion.

Main Results:

• Prognosis varies significantly by EBTB type; actively caseating and edematous-hyperemic types have grave prognoses, often leading to fibrostenosis.
• Granular and non-specific bronchitic types have good prognoses, while the tumorous type has a poor prognosis.
• Antituberculous chemotherapy controls infection but doesn't prevent residual bronchostenosis; early steroid therapy and procedures like balloon dilatation show effectiveness.

Conclusions:

• EBTB management requires understanding its diverse types and prognoses.
• While chemotherapy is essential, it must be complemented by other treatments to address bronchostenosis.
• Further research into the inflammatory and fibrotic processes of EBTB is needed to develop strategies for preventing bronchial stenosis.